How Much Weight Can You Lose on Ozempic? 2026 Clinical Data & Real Results

Clinical Trial Weight Loss Results for Ozempic (Semaglutide)

The most cited evidence for how much weight you can lose on Ozempic comes from the STEP clinical trial program, which tested semaglutide 2.4 mg (marketed as Wegovy for weight loss) in adults with obesity. Ozempic (semaglutide 1 mg and 2 mg) is FDA-approved for type 2 diabetes but is widely prescribed off-label for weight loss.

Here's what the data shows at the standard dosing levels:

STEP 1 Trial: 68-Week Results

STEP 2 Trial: Patients with Type 2 Diabetes

Patients with type 2 diabetes typically lose less weight on Ozempic than non-diabetic patients — roughly 5–10% vs. 12–15%. This is thought to be due to the metabolic differences in insulin resistance and the fact that some diabetes medications promote weight gain.

Want to estimate your own projected weight loss? Use our Ozempic Weight Loss Calculator — enter your current weight, height, and dosage to get a personalized 6-month and 12-month projection.

Week-by-Week Weight Loss Timeline on Ozempic

Weight loss on Ozempic is not linear. Most people experience rapid early results, followed by a gradual slowdown as the body adapts. Here is a general timeline based on clinical data and patient-reported outcomes:

Weeks 1–4: Dose Escalation Phase

You start at 0.25 mg weekly, which is a sub-therapeutic dose designed to minimize side effects. Weight loss during this phase is minimal — typically 1–3 pounds. Most of this early loss is water weight and reduced caloric intake from appetite suppression beginning to kick in.

Weeks 5–16: Early Weight Loss Phase

As you titrate up to 0.5 mg and then 1 mg, appetite suppression becomes significant. Many patients report losing 1–2 pounds per week during this phase. By week 12, average weight loss in clinical trials was approximately 5–7% of starting body weight. If you started at 220 lbs, that's 11–15 pounds in three months.

Weeks 17–36: Peak Weight Loss Phase

This is where the most dramatic results occur. At the 2 mg dose (for those who titrate up), weekly losses of 0.5–1.5 lbs are common. Cumulative weight loss by the 6-month mark is often 8–12% of starting body weight. A 250-pound person might be down 20–30 pounds at this stage.

Weeks 37–68: Plateau and Stabilization

Weight loss slows significantly after month 6–8. The body has adapted its metabolism to defend a new, lower set point. Many patients report losing just 0.25–0.5 lbs per week during this phase. However, cumulative results by week 68 average 12–15% total body weight loss.

Summary Table: Expected Weight Loss by Starting Weight

Estimates based on 5–7% at 3 months, 8–12% at 6 months, 12–15% at 12 months. Individual results vary significantly.

Factors That Affect How Much Weight You Lose on Ozempic

The clinical trial average of 14.9% body weight loss represents a population average — your individual results will depend on several key variables:

1. Dose

Higher doses produce greater weight loss. Patients who reached the 2.4 mg dose of semaglutide (Wegovy) lost significantly more than those on 1 mg (standard Ozempic dose). If you are prescribed Ozempic at 1 mg for diabetes management, your weight loss target should be more conservative — typically 5–8% of body weight.

2. Diet and Exercise Habits

In the STEP trials, all participants received lifestyle counseling and reduced-calorie diet guidance. Patients who combined semaglutide with a structured 500-calorie daily deficit and regular exercise lost substantially more than those who relied on the medication alone. Aim for 150 minutes of moderate activity per week and prioritize protein intake to preserve muscle mass.

3. Baseline BMI

People with higher starting BMIs tend to lose more pounds but similar percentages of body weight. Someone at 300 lbs will lose more absolute weight than someone at 180 lbs, but both may lose approximately 12–15% of their starting weight.

4. Whether You Have Type 2 Diabetes

As noted above, T2D significantly reduces weight loss response. If you have diabetes, target 5–10% weight loss over 12 months on Ozempic rather than the 12–15% seen in non-diabetic populations.

5. Genetics and Individual Response

GLP-1 receptor sensitivity varies genetically. Some people are "super responders" who lose 20%+ of body weight; others are non-responders who see minimal weight loss even at maximum doses. Unfortunately, there is no reliable way to predict your response before starting treatment.

6. Medication Consistency

Missing doses significantly reduces effectiveness. Ozempic's once-weekly dosing is designed for consistency — the half-life of semaglutide is about 7 days, so missing a week drops drug levels substantially.

Real-World Weight Loss Results vs. Clinical Trials

Real-world data consistently shows lower weight loss than clinical trials, for several reasons:

• Clinical trial participants receive intensive behavioral support and regular check-ins
• Trial participants are often more motivated and adherent than average patients
• Real-world patients frequently have more comorbidities and competing medications
• Insurance coverage gaps cause interruptions in therapy
• Supply shortages (ongoing in 2026) disrupt dosing schedules

Real-world studies published in 2025 show average weight loss of 8–11% over 12 months, compared to 14.9% in clinical trials. This is still clinically significant — a 10% weight reduction reduces cardiovascular risk, improves blood sugar, and decreases joint stress substantially.

A 2025 analysis of 50,000 insured US patients found that only 42% remained on semaglutide therapy at 12 months. The primary reasons for discontinuation were cost, side effects, and supply issues. Patients who stayed on therapy for the full year lost an average of 12.3% of body weight.

How to Maximize Weight Loss on Ozempic

To get the most out of Ozempic therapy, follow these evidence-based strategies:

Prioritize Protein Intake

Ozempic causes significant appetite suppression, which can lead to inadequate protein intake and muscle loss. Aim for 1.2–1.6 grams of protein per kilogram of body weight daily. For a 220-pound (100 kg) person, that means 120–160 grams of protein per day. Use our GLP-1 Protein Calculator to get a personalized protein target.

Resistance Training

Research shows that GLP-1 users who do resistance training (weightlifting, body weight exercises) lose significantly more fat and preserve more muscle than those who only do cardio or no exercise. Aim for 2–3 strength sessions per week.

Don't Skip the Titration Phase

Rushing through dose titration to reach maximum dose faster actually backfires — it increases side effects like nausea and vomiting, which cause people to stop the medication early. Follow the standard 4-week titration schedule your prescriber recommends.

Track Your Progress

Weigh yourself weekly (not daily) and track trends over 4-week periods. Weight loss is not linear — expect weeks where the scale doesn't move or even goes up slightly due to water retention, hormonal fluctuations, or muscle gain.

Address Sleep and Stress

Poor sleep and high cortisol levels directly impair weight loss even on GLP-1 medications. Patients who sleep less than 7 hours per night consistently lose less weight in clinical observations. Prioritize sleep hygiene alongside your medication.

What to Do When You Hit a Weight Loss Plateau on Ozempic

Most patients hit a significant plateau between months 6 and 9. This is normal and expected — it does not mean the medication has stopped working. Here is how to work through it:

• Reassess calories: As you lose weight, your caloric needs decrease. What was a deficit at 250 lbs may be maintenance at 220 lbs. Recalculate your needs.
• Increase protein: Higher protein intake supports continued fat loss while preserving muscle during a plateau phase.
• Discuss dose adjustment with your prescriber: Some patients benefit from titrating to a higher dose (2 mg) if they have plateaued at 1 mg and have adequate tolerance.
• Add or vary exercise: The body adapts to exercise patterns. Switching from walking to resistance training, or adding HIIT, can break a plateau.
• Consider medication combinations: Some prescribers add tirzepatide (Mounjaro/Zepbound) or other medications for patients who plateau on semaglutide. This is off-label and requires careful medical supervision.

Plateaus lasting more than 8 weeks despite adherence to diet and exercise are worth discussing with your prescriber. A plateau is not treatment failure — it is a signal to reassess your approach.